Literature DB >> 6874959

Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism.

M F Attie, J R Gill, J L Stock, A M Spiegel, R W Downs, M A Levine, S J Marx.   

Abstract

Familial hypocalciuric hypercalcemia (FHH) is an autosomal dominant trait comprising hypercalcemia, hypophosphatemia, parathyroid hyperplasia, and unusually low renal clearance of calcium. We evaluated the role of parathyroid hormone in the relative hypocalciuria of FHH and characterized the renal transport of calcium in this disorder using three previously hypercalcemic FHH patients with surgical hypoparathyroidism and three controls with surgical hypoparathyroidism. Intravenous infusion of calcium chloride in two patients with FHH and in three controls increased serum calcium from a mean basal of 5.0 to a mean peak of 6.8 meq/liter in two FHH patients and from 4.2 to 5.7 in three control subjects. Urinary calcium in a third FHH patient was studied without calcium infusion during recovery from hypercalcemia of vitamin D intoxication. At all serum concentrations of calcium, calcium clearance was lower in FHH than in controls; at base-line serum calcium, the ratio of calcium clearance to inulin clearance (C(Ca)/C(IN)) in FHH subjects was 32% of that in controls and decreased to 19% during hypercalcemia. Calcium infusion increased the ratio of sodium clearance to inulin clearance in controls from a base line of 0.020 to 0.053 at peak concentrations of calcium in serum, but did not affect this parameter in FHH (0.017 at base-line serum calcium vs. 0.019 at peak). When calcium infusion studies were performed (in two patients with FHH and one control) during administration of acetazolamide, a drug whose principal renal action causes inhibition of proximal transport of solute, C(Ca)/C(IN) in the patients with FHH was 29 and 7% of that of the control at base-line and peak serum calcium, respectively. In contrast, ethacrynic acid, a diuretic that acts in the ascending limb of the loop of Henle, increased C(Ca)/C(IN) more in the FHH patients than in the control subject; C(Ca)/C(IN) was 65% at base-line and 47% at peak serum calcium, compared with that of the control subject. The greater calciuric response to ethacrynic acid than to acetazolamide or calcium infusion alone in FHH indicates that a major renal locus of abnormal calcium transport in this disorder may be the ascending limb of the loop of Henle.Decreased clearance of calcium in patients with FHH and hypoparathyroidism when compared with hypoparathyroid controls indicates that relative hypocalciuria in FHH is not dependent on hyperparathyroidism. Since the parathyroid glands in FHH are not appropriately suppressed by calcium, this implies that FHH represents a disorder of abnormal transport of, and/or response to, extracellular calcium in at least two organs, parathyroid gland and kidney.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6874959      PMCID: PMC1129226          DOI: 10.1172/jci111016

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  The renal clearance of alkali-stable inulin.

Authors:  M WALSER; D G DAVIDSON; J ORLOFF
Journal:  J Clin Invest       Date:  1955-10       Impact factor: 14.808

2.  Natriuretic effect of calcitonin in man.

Authors:  O L Bijvoet; J van der Sluys Veer; H R de Vries; A T van Koppen
Journal:  N Engl J Med       Date:  1971-04-01       Impact factor: 91.245

3.  Relation between serum and urinary calcium with particular reference to parathyroid activity.

Authors:  M Peacock; W G Robertson; B E Nordin
Journal:  Lancet       Date:  1969-02-22       Impact factor: 79.321

4.  Familial benign hypercalcemia.

Authors:  T P Foley; H C Harrison; C D Arnaud; H E Harrison
Journal:  J Pediatr       Date:  1972-12       Impact factor: 4.406

5.  Modification of calciuretic effect of extracellular volume expansion by phosphate infusion.

Authors:  J W Coburn; D L Hartenbower; S G Massry
Journal:  Am J Physiol       Date:  1971-02

6.  Divalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.

Authors:  S J Marx; A M Spiegel; E M Brown; J O Koehler; D G Gardner; M F Brennan; G D Aurbach
Journal:  Am J Med       Date:  1978-08       Impact factor: 4.965

7.  The spectrum of hypoparathyroidism.

Authors:  A M Parfitt
Journal:  J Clin Endocrinol Metab       Date:  1972-01       Impact factor: 5.958

8.  Effect of parathyroid extract on magnesium excretion in man.

Authors:  J R Gill; N H Bell; F C Bartter
Journal:  J Appl Physiol       Date:  1967-01       Impact factor: 3.531

9.  Radioimmunoassay for the middle region of human parathyroid hormone: studies with a radioiodinated synthetic peptide.

Authors:  S J Marx; M E Sharp; A Krudy; M Rosenblatt; L E Mallette
Journal:  J Clin Endocrinol Metab       Date:  1981-07       Impact factor: 5.958

10.  Maximal urine-concentrating ability: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.

Authors:  S J Marx; M F Attie; J L Stock; A M Spiegel; M A Levine
Journal:  J Clin Endocrinol Metab       Date:  1981-04       Impact factor: 5.958

View more
  22 in total

Review 1.  Primary hyperparathyroidism: pathophysiology and impact on bone.

Authors:  A Khan; J Bilezikian
Journal:  CMAJ       Date:  2000-07-25       Impact factor: 8.262

Review 2.  Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations.

Authors:  Ogo I Egbuna; Edward M Brown
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

Review 3.  Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.

Authors:  Stephen J Marx; David Goltzman
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

4.  In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.

Authors:  M Bai; S H Pearce; O Kifor; S Trivedi; U G Stauffer; R V Thakker; E M Brown; B Steinmann
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

5.  Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene.

Authors:  Stephen J Marx; Ninet Sinaii
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

Review 6.  Familial hypocalciuric hypercalcaemia--familial benign hypercalcaemia: a review.

Authors:  J Auwerx; J Brunzell; R Bouillon; M Demedts
Journal:  Postgrad Med J       Date:  1987-10       Impact factor: 2.401

Review 7.  New functional aspects of the extracellular calcium-sensing receptor.

Authors:  Hakan R Toka
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-07       Impact factor: 2.894

Review 8.  Familial hypocalciuric hypercalcemia and related disorders.

Authors:  Janet Y Lee; Dolores M Shoback
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-05-26       Impact factor: 4.690

Review 9.  Physiology and pathophysiology of the calcium-sensing receptor in the kidney.

Authors:  Daniela Riccardi; Edward M Brown
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-18

10.  Calcium-sensing receptor signaling pathways in medullary thick ascending limb cells mediate COX-2-derived PGE2 production: functional significance.

Authors:  Huda Ismail Abdullah; Paulina L Pedraza; John C McGiff; Nicholas R Ferreri
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.